NCT06207656
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06207656
Title Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer (CEBBRA)
Acronym CEBBRA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD) RECRUITING Madrid 28046 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field